cardiomyopathy final

Upload: michael-thorn

Post on 09-Apr-2018

223 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/8/2019 Cardiomyopathy Final

    1/17

    CADRIOMYOPATHY

    Presented by

    Whitney Jack

    November 20th, 2010

  • 8/8/2019 Cardiomyopathy Final

    2/17

  • 8/8/2019 Cardiomyopathy Final

    3/17

  • 8/8/2019 Cardiomyopathy Final

    4/17

    What is Cardiomyopathy

    Cardiomyopathy is a general term used todescribe a diverse group of diseases of theheart muscle.

    For most people with Cardiomyopathy, their

    hearts don't function normally because theheart has become either enlarged,abnormally thick, or abnormally rigid.

    As Cardiomyopathy worsens, the heartbecomes weaker. It's less able to pumpblood through the body and maintain a

    normal electrical rhythm. This can leadto heart failure causing fluid to build up inthe lungs, ankles, feet, legs, or abdomen.

  • 8/8/2019 Cardiomyopathy Final

    5/17

    Why I chose this topic

    I have an interest in the diseasecardiomyopathy

    My grandpa, has been strugglingwith heart disease for the past

    twenty year. Through his heartdisease struggle he hasdeveloped the diseasecardiomyopathy.

    To further my knowledge in thedisease

    Have a better understanding ofcardiomyopathy-Advocate

  • 8/8/2019 Cardiomyopathy Final

    6/17

    Risk Factors for Cardiomyopathy

    Coronary artery disease Exposure to toxic agents such

    as cocaine, methamphetamines,

    and heroin

    Heart valve defects

    Myocarditis (inflammation ofthe walls of the heart)

    Sleep apnea

    Sustained, untreated high

    blood pressure

    Sustained heavy alcoholconsumption

    Hemochromatosis, in which iron

    is deposited in the cells of the

    heart muscle.

    Radiation to the chest and

    some chemotherapy drugs, such

    as anthracycline

  • 8/8/2019 Cardiomyopathy Final

    7/17

    Signs andSymptoms

    As cardiomyopathy worsens andthe heart weakens, signs and

    symptoms of heart failure usually

    occur. These signs and symptoms

    include:

    Shortness of breath or trouble

    breathing.

    Fatigue (tiredness).

    Swelling in the ankles, feet, legs, and

    abdomen. Rarely, swelling may occur in

    the veins of your neck.

    dizziness, lightheadedness, fainting

    during physical activity chest pain, dysrhythmias and heart

    murmurs (an extra or unusual sound

    heard during a heartbeat).

  • 8/8/2019 Cardiomyopathy Final

    8/17

    Diagnostic Testing

    Chest X Ray This test can showwhether your heart is enlarged.

    Echocardiography a test that uses

    sound waves to create a moving

    picture of your heart. The picture

    shows how well your heart is

    working and its size and shape.

    Cardiac Catheterization a

    procedure checks the pressure and

    blood flow in your heart's

    chambers. The procedure also

    allows your doctor to collect bloodsamples and look at your heart's

    arteries using x-ray imaging. This

    allows your doctor to study the

    inside of your arteries to look for

    blockages.

    EKG (Electrocardiogram) a

    simple test that records the

    heart's electrical activity.

    T

    his test shows how fast yourheart is beating and

    whether the rhythm of your

    heartbeat is steady or

    irregular. EKG results can

    suggest disorders such as

    heart failure.

  • 8/8/2019 Cardiomyopathy Final

    9/17

    Statistics andPopulations with

    Cardiomyopathy

    87 percent of cases are dilated

    cardiomyopathy.

    50 percent of patients with dilated

    cardiomyopathy are alive 5 years

    after their initial diagnosis

    25 percent are alive 10 years after

    the diagnosis. (2)

    Mortality from cardiomyopathy is

    highest in older persons, men and

    blacks.

    Studies show that 36 percent of

    young athletes who die suddenlyhave definite hypertrophic

    cardiomyopathy.

    26,8

    00 people die in the USeach year from some sort of

    cardiomyopathy.

  • 8/8/2019 Cardiomyopathy Final

    10/17

  • 8/8/2019 Cardiomyopathy Final

    11/17

    DilatedCardiomyopathy

    Most common type of

    cardiomyopathy

    The heart muscle becomes dilated

    and leads to enlargement of the

    muscle but doesnt mean these

    larger muscles are stronger.

    Excessive alcohol use is the main

    cause for this type of

    cardiomyopathy

    Top heart condition during

    complication in pregnancy

  • 8/8/2019 Cardiomyopathy Final

    12/17

    Restrictive Cardiomyopathy

    VERY rare in the U.S. but can

    be a common heart condition in

    underdeveloped and third

    world countries.

    The walls of the ventriclesbecome stiffened and are then

    unable to act as a pump to

    provide oxygenated blood to

    the body.

    Doesnt appear to be inherited

    but seen as being idiopathic

    (unknown cause).

  • 8/8/2019 Cardiomyopathy Final

    13/17

    ICDs andPacemakers

    A pacemaker is a medical devicewhich uses electrical impulses,

    delivered by electrodes contacting the

    heart muscles, to regulate the beating

    of the heart.

    The implantable cardioverter-defibrillator (ICD) is the most reliable

    and effective treatment for

    cardiomyopathy patients at high-risk.

    It has the potential to alter the

    disease course by automaticallysensing and terminating lethal

    disturbances of heart rhythm,often in

    young people with little or no

    symptoms.

  • 8/8/2019 Cardiomyopathy Final

    14/17

    Medications and Lifestyle Changes

    Quitting smoking

    Losing excess weight

    Avoiding the use of alcohol

    and illegal drugs

    Reducing stress

    Not engage in vigorousexercising

    Make sure you go to all of

    your medical checkups.

    Follow your treatments for

    any underlying conditions,such as diabetes and high

    blood pressure

    Medicines can help manage

    symptoms and improve heart action.Diuretics reduce excess fluid in

    the body.

    Vasodilators relax blood vessels

    and help to lower blood pressure.

    Digoxin helps to improve the

    heart's pumping action.

    Beta Blockers help to keep a

    regular heartbeat and lessen the

    work of the heart muscle.

  • 8/8/2019 Cardiomyopathy Final

    15/17

    Nurses Role in Helping Patients with

    Cardiomyopathy

    Emotional support, frequent teaching,

    providing educational printouts or brochures

    Counseling to assist in patient and family

    coping.

    Ensuring that Medic-Alert bracelets are

    available for patients with cardiomyopathy

    to prevent confusion in an emergency

    situation.

    Close supervision of electrolyte and hydration

    status must be a priority because these

    patients are on medications that alterelectrolyte levels and fluid status.

    These patients are generally restricted fromplaying competitive sports, the rationaleshould be explained thoroughly because ofthe stress on the heart; other types of

    exercises should be addressed.

  • 8/8/2019 Cardiomyopathy Final

    16/17

    Any Questions???

  • 8/8/2019 Cardiomyopathy Final

    17/17

    References & Sources About Cardiomyopathy - US News Health. (2008, December 31).Health News Articles - US News Health.

    Retrieved October 30, 2010, from http://health.usnews.com/health-conditions/heart-health/cardiomyopathy American Heart Association.Heart Disease and Stroke Statistics 2005 Update. Dallas, Texas.: American

    Heart Association; 2005.

    Cardiomyopathy management and lifestyle. (n.d.).National Heart, Lung and Blood Institute. Retrieved

    November 20, 2010, from http://www.nhlbi.nih.gov/health/dci/Diseases/cm/cm_living.html

    Dilated Cardiomyopathy - Texas Heart Institute Heart Information Center. (1996-2010). Texas Heart

    Institute. Retrieved October 30, 2010, from http://www.texasheart.org/hic/topics/cond/dilated.cfm

    Maron, B., Francis, J., & Ghosh, J. (2005). Role of Implantable Cardioverter Devices in the Treatment ofHypertrophic Cardiomyopathy Patients.Journal of Indian Pacing Electrophysiology, 5(2), 72-75. Retrieved

    November 20, 2010, from Pub Med.

    Maron, B. J. (2002). Hypertrophic Cardiomyopathy -- Maron 106 (19): 2419 -- Circulation.Homepage

    Spotlight File. Retrieved October 30, 2010, from http://circ.ahajournals.org/cgi/content/full/106/19/2419

    NHLBI, Cardiomyopathy: NHLBI - WrongDiagnosis.com. (1997, July). Wrong Diagnosis. Retrieved

    October 27, 2010, from http://www.wrongdiagnosis.com/artic/nhlbi_cardiomyopathy_nhlbi.htm

    O'Rourke, R. (1999). Cardiac Pacing: An Alternative Treatment for Selected Patients with Cardiomyopathy.

    Circulation, (100), 786-788.

    Stromberg, A. (n.d.). The crucial role of patient education in heart failure Eur J Heart Fail.European

    Journal of Heart Failure, 7(3), 363-369. Retrieved October 26, 2010, from

    http://eurjhf.oxfordjournals.org/content/7/3/363.full

    Willingham Muzzy Pediatric Molecular Cardiology Laboratory - RCM. (n.d.).Baylor College of Medicine -

    Houston, Texas. Retrieved November 20, 2010, from

    http://www.bcm.edu/pediatrics/index.cfm?Realm=99992426&This_Template=RCM